Suppr超能文献

经皮冠状动脉介入治疗前 Mehran 评分预测急性肾损伤的性能。

Performance of a pre-procedural Mehran score to predict acute kidney injury after percutaneous coronary intervention.

机构信息

GME department, University of Central Florida College of Medicine, Orlando, Florida, USA.

Ocala Regional Medical Center Internal Medicine Residency Program, Ocala, Florida, USA.

出版信息

Nephrology (Carlton). 2021 Jan;26(1):23-29. doi: 10.1111/nep.13769. Epub 2020 Sep 9.

Abstract

AIM

Acute kidney injury (AKI) is a known complication of patients undergoing cardiac catheterization or percutaneous coronary interventions (PCI).The Mehran score was developed to identify patients at risk for AKI after cardiac catheterization or PCI, but its use of contrast volume as part of the score calculation limits its application prior to the procedure. In this study, we evaluated the utility of a modified Mehran score that utilizes only pre-procedural data by excluding contrast volume.

METHODS

This was done in a retrospective fashion using data from patients who received PCI at our institution between July 2015 and December 2017 by evaluating the discriminative ability of the scoring systems for predicting outcomes through a receiver-operator characteristic curve analysis.

RESULTS

One thousand five hundred and seven patients were included in the study. A total of 70 (4.6%) patients developed AKI. The removal of contrast volume from the Mehran score resulted in a small loss of discrimination with AUROC 0.73 vs 0.74, P = .01 for the pre-procedural Mehran and the original Mehran, respectively. When compared to the original score, the pre-procedural Mehran score had a four-category net discrimination index (NRI) of -0.10 and an integrated discrimination index (IDI) for of -0.12.

CONCLUSION

Despite a small loss in discrimination, there was no difference in the four-category net discrimination index between the two scores. The pre-procedural modified Mehran score is a useful clinical predictor of the risk of AKI in patients undergoing PCI.

摘要

目的

急性肾损伤(AKI)是接受心脏导管检查或经皮冠状动脉介入治疗(PCI)的患者的已知并发症。Mehran 评分用于识别心脏导管检查或 PCI 后发生 AKI 的患者,但由于其使用造影剂体积作为评分计算的一部分,因此限制了其在术前的应用。本研究通过排除造影剂体积,评估了仅使用术前数据的改良 Mehran 评分的应用。

方法

本研究采用回顾性研究方法,使用我院 2015 年 7 月至 2017 年 12 月接受 PCI 的患者的数据,通过接受者操作特征曲线分析评估评分系统预测结果的判别能力。

结果

本研究共纳入 1570 例患者,其中 70 例(4.6%)患者发生 AKI。Mehran 评分中去除造影剂体积后,判别能力略有下降,术前 Mehran 和原始 Mehran 的 AUROC 分别为 0.73 和 0.74,P =.01。与原始评分相比,术前 Mehran 评分的净判别改善指数(NRI)为-0.10,综合判别改善指数(IDI)为-0.12。

结论

尽管判别能力略有下降,但两种评分的四分类净判别改善指数无差异。术前改良 Mehran 评分是预测 PCI 患者 AKI 风险的有用临床指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验